Federal Ministry of Research, Technology and Space (BMFTR)

• Research Building Multidimensional Trauma Sciences (MTW) (Funding according to article 91b GG; Speaker: Prof. Dr. M. Huber-Lang, Institute for Clinical and Experimental Trauma Immunology)
• NCT SouthWest, Site of the National Center for Tumor Diseases (NCT), Cooperation between Comprehensive Cancer Center Tübingen-Stuttgart and Comprehensive Cancer Center Ulm (Speaker: Prof. Dr. L. Zender, Department of Internal Medicine VIII, Tübingen University Hospital)
• Interdisciplinary Scientific Center for Fertility Preservation (FePro-​Ulm) (Funded under the BMFTR program for interdisciplinary young academics centers for reproductive health; Speakers: Prof. Dr. K. Hancke, PD Dr. Dr. K. Bundschu, Department of Gynecology and Obestetrics)
• Early Intervention at the Workplace (friaa) (Speaker: PD Dr. E. Rothermund, Prof. Dr. H. Gündel, K. Herrmann, Department of Psychosomatic Medicine and Psychotherapy); successfully concluded on September 30, 2024

Federal Ministry of Defence (BMVg)

• Development of regenerative therapies for the treatment of tissue injuries; Cooperation with the Military Hospital Ulm (Speaker: Prof. Dr. A. Ignatius, Institute of Orthopaedic Research and Biomechanics)

Innovation Fund of the Federal Joint Committee (G-BA) – Health Services Research

• EMPOWER-TRANS* – Entwicklung und Implementierung innovativer, digitaler Informations- und Schulungskonzepte für Kinder und Jugendliche mit Geschlechtsinkongruenz/Geschlechtsdysphorie (GI/GD) und ihre Familien (Speaker: Prof. Dr. Annette Richter-Unruh, Department of Pediatrics and Adolescent Medicine)
• IPS-Pilot – Integrierte Psychosoziale Versorgung in der Intensivmedizin: Partizipative Entwicklung und Pilotierung eines innovativen Versorgungsansatzes (Speaker: Prof. Dr. Harald Gündel, Department of Psychosomatic Medicine and Psychotherapy)
• EPPIK – Überprüfung der Eignung des ‚Plattformmodells‘ als Instrument zur Personalbemessung in psychiatrischen und psychosomatischen Kliniken (Speaker: Dr. Markus Kösters, Department of Psychiatry and Psychotherapy II); successfully concluded March 31, 2024
• QualiPäd – Evaluation der Versorgungsqualität in der ambulanten Routineversorgung häufiger Erkrankungen des Kindes- und Jugendalters (Speaker: Prof. Dr. Dr. Christian Bachmann, Department of Child and Adolescent Psychiatry/Psychotherapy); successfully concluded March 31, 2024

Joint Programming Initiatives

• Hypothalamic mechanisms of High-Calorie intervention in ALS (HiCALS) (Speaker: Prof. Dr. F. Roselli, Department of Neurology)

Graduate School:

• International Graduate School in Molecular Medicine Ulm (Board of Directors: Prof. Dr. B. Knöll [Chairman, Institute of Neurobiochemistry], Prof. Dr. M. Frick [Vice-Chairman, Institute of General Physiology], Prof. Dr. D. Rautenbach [Vice-President Career of Ulm University], PD Dr. M. Vujić Spasić [Vice-Chairman, Institute of Comparative Molecular Endocrinology]); Funded by the Excellence Initiative of the German Federal and State Governments until October 31, 2019; continued funding by the State of Baden-Württemberg and the Medical Faculty.

Initiative funded by Baden-Württemberg Foundation:

• Join the Healthy Boat - program for health promotion in kindergartens and primary schools (Speaker: Prof. Dr. J. Steinacker, Section Sports and Rehabilitation Medicine)

SARS-CoV-2 and Long COVID Programs:

The Medical Faculty is involved in several projects investigating SARS-CoV-2 and Long COVID under special funding program of the State of Baden-Württemberg. Among the youngest projects, one network is coordinated in Ulm:

• A PILOT Study – App-based exercise training intervention for Long- and Post-COVID treatment (Speaker: Prof. Dr. J. Steinacker, Section Sports and Rehabilitation Medicine), successfully concluded November 30, 2024.

Research Center in Public-Private Partnership:

• Boehringer Ingelheim Ulm University BioCenter (BIU). Topics: neuropsychiatric, cardio metabolic and lung diseases as well as immunmodulatory aspects (Speaker BIU 2.0: Prof. Dr. K.-M. Debatin; Speaker BIU 3.0: Prof. Dr. P. Fischer-Posovszky, Department of Pediatrics and Adolescent Medicine)

Center of Excellence in Oncology funded by the German Cancer Aid:

• Comprehensive Cancer Center Ulm (CCCU) (Speaker: Prof. Dr. St. Stilgenbauer, Department of Internal Medicine III)

Forschungskolleg funded by the Else Kröner-Fresenius-Stiftung:

• Else Kröner-Forschungskolleg: Entwicklung und Etablierung prädiktiver Modelle zur Realisierung von personalisierter Tumortherapie (Speaker: Prof. Dr. A. Kleger, Prof. Dr. T. Seufferlein, Department of Internal Medicine I)

Research Center funded by the Charcot Foundation:

• ALS Research Center (Speaker: Prof. Dr. A.C. Ludolph, Department of Neurology)

Research Network funded by the CHDI Foundation:

• The Euro Huntington’s Disease Network (Speaker: Prof. Dr. B. Landwehrmeyer, Department of Neurology)

German Centers for Health Research:

• Site of DZNE - German Center for Neurodegenerative Diseases within the Helmholtz Association (Site Speaker: Prof. Dr. A.C. Ludolph, Department of Neurology)
• Site of DZKJ - German Center for Child and Adolescent Health (Site Speaker: Prof. Dr. K.-M. Debatin, Department of Pediatrics and Adolescent Medicine)
• Member of the Mannheim-Heidelberg-Ulm Site of DZPG - German Center for Mental Health (Coordination: ZI Mannheim; Speaker Ulm: Prof. Dr. J.M. Fegert, Department of Child and Adolescent Psychiatry/Psychotherapy)

Furthermore, Prof. Reinhard Holl (Institute of Epidemiology and Medical Biometry) and Prof. Martin Heni (Department of Internal Medicine I) are project partners in the German Center for Diabetes Research (DZD) and Prof. Ole Ammerpohl (Institute of Human Genetics) is Principal Investigator in the German Center for Lung Research (DZL).